AGN 4.35% 72.0¢ argenica therapeutics limited

Ann: Phase 2 Stroke Clinical Trial Update, page-31

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 875 Posts.
    lightbulb Created with Sketch. 217
    @Aki23

    The upside from this is that they want the drug given in the field eventually by paramedics when they think a patient may be having a stroke. Lots of these patients end up not having strokes when they go through the scanner in ED.
 
watchlist Created with Sketch. Add AGN (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.